(a) Subject to subsection (d), every infant shall be given examinations at the earliest feasible time for the detection of the following disorders:
(3) Hemoglobinopathies, including sickle cell anemia.
(5) Maple Syrup urine disease.
(7) Inborn errors of metabolism that result in an intellectual disability and that are designated by the state department.
(8) Congenital adrenal hyperplasia.
(9) Biotinidase deficiency.
(10) Disorders detected by tandem mass spectrometry or other technologies with the same or greater detection capabilities as tandem mass spectrometry, if the state department determines that the technology is available for use by a designated laboratory under section 7 of this chapter.
(11) Spinal muscular atrophy.
(12) Severe combined immunodeficiency.
(13) Beginning July 1, 2020, Krabbe disease.
(14) Beginning July 1, 2020, Pompe disease.
(15) Beginning July 1, 2020, Hurler syndrome (MPS1).
(b) Subject to subsection (d), every infant shall be given a physiologic hearing screening examination at the earliest feasible time for the detection of hearing impairments.
(c) Beginning January 1, 2012, and subject to subsection (d), every infant shall be given a pulse oximetry screening examination at the earliest feasible time for the detection of low oxygen levels. Section 10(a)(2) of this chapter does not apply to this subsection.
(d) If a parent of an infant objects in writing, for reasons pertaining to religious beliefs only, the infant is exempt from the examinations required by this chapter.
FindLaw Codes are provided courtesy of Thomson Reuters Westlaw, the industry-leading online legal research system. For more detailed codes research information, including annotations and citations, please visit Westlaw.
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.